Inbrain will apply Microsoft's agentic AI and cloud tech to its brain-computer interface, which could facilitate faster ...
The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...
A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...
Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...
The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.
Researchers propose a novel closed-loop system merging brain-computer interfaces and peripheral nerve stimulation to enable ...
Researchers at Washington University in St. Louis say they created a fiber-optic device that can manipulate neural activity ...
Reading brain activity with advanced technologies is not a new concept. However, most techniques have focused on identifying ...
The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results